Antibody That Destroys Ghrelin Increases Metabolism and Reduces Refeeding in Mice

A catalytic antibody that degrades ghrelin increased whole-body metabolic rate and reduced refeeding after fasting in mice — a novel immunological approach to ghrelin blockade for obesity treatment.

Mayorov, Alexander V et al.·Proceedings of the National Academy of Sciences of the United States of America·2008·Preliminary EvidenceAnimal StudyAnimal Study
RPEP-01384Animal StudyPreliminary Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

A ghrelin-degrading catalytic antibody (ghrelin-ase) increased metabolic rate and reduced post-fast refeeding in mice, demonstrating an immunological approach to ghrelin neutralization for obesity treatment — antibody-based appetite suppression.

Key Numbers

How They Did This

animal-study study.

Why This Research Matters

Relevant for neuropeptides, weight-loss, peptide-design.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding A ghrelin-degrading catalytic antibody (ghrelin-ase) increased metabolic rate and reduced post-fast refeeding in mice, demonstrating an immunological
Evidence Grade:
preliminary evidence.
Study Age:
Published in 2008.
Original Title:
Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice.
Published In:
Proceedings of the National Academy of Sciences of the United States of America, 105(45), 17487-92 (2008)
Database ID:
RPEP-01384

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Antibody That Destroys Ghrelin Increases Metabolism and Reduces Refeeding in Mice

What was found?

A catalytic antibody that degrades ghrelin increased whole-body metabolic rate and reduced refeeding after fasting in mice — a novel immunological approach to ghrelin blockade for obesity treatment.

Read More on RethinkPeptides

Cite This Study

RPEP-01384·https://rethinkpeptides.com/research/RPEP-01384

APA

Mayorov, Alexander V; Amara, Neri; Chang, Jason Y; Moss, Jason A; Hixon, Mark S; Ruiz, Diana I; Meijler, Michael M; Zorrilla, Eric P; Janda, Kim D. (2008). Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice.. Proceedings of the National Academy of Sciences of the United States of America, 105(45), 17487-92. https://doi.org/10.1073/pnas.0711808105

MLA

Mayorov, Alexander V, et al. "Catalytic antibody degradation of ghrelin increases whole-body metabolic rate and reduces refeeding in fasting mice.." Proceedings of the National Academy of Sciences of the United States of America, 2008. https://doi.org/10.1073/pnas.0711808105

RethinkPeptides

RethinkPeptides Research Database. "Catalytic antibody degradation of ghrelin increases whole-bo..." RPEP-01384. Retrieved from https://rethinkpeptides.com/research/mayorov-2008-catalytic-antibody-degradation-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.